|
1
|
Mucke L: Neuroscience: Alzheimer's
disease. Nature. 461:895–897. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Brookmeyer R, Johnson E, Ziegler-Graham K
and Arrighi HM: Forecasting the global burden of Alzheimer's
disease. Alzheimers Dement. 3:186–191. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Armstrong RA: What causes Alzheimer's
disease. Folia Neuropathol. 51:169–188. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bertram L and Tanzi RE: Genome-wide
association studies in Alzheimer's disease. Hum Mol Genet.
18:R137–R145. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Scacchi R, Gambina G, Moretto G and Corbo
RM: Variability of AChE, BChE, and ChAT genes in the late-onset
form of Alzheimer's disease and relationships with response to
treatment with Donepezil and Rivastigmine. Am J Med Genet B
Neuropsychiatr Genet. 150B:502–507. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Borroni B, Costanzi C and Padovani A:
Genetic susceptibility to behavioural and psychological symptoms in
Alzheimer disease. Curr Alzheimer Res. 7:158–164. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Serretti A, Olgiati P and De Ronchi D:
Genetics of Alzheimer's disease. A rapidly evolving field. J
Alzheimers Dis. 12:73–92. 2007.PubMed/NCBI
|
|
8
|
Maisonpierre PC, Le Beau MM, Espinosa R
III, Ip NY, Belluscio L, de la Monte SM, Squinto S, Furth ME and
Yancopoulos GD: Human and rat brain-derived neurotrophic factor and
neurotrophin-3: Gene structures, distributions, and chromosomal
localizations. Genomics. 10:558–568. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ferrer I, Marín C, Rey MJ, Ribalta T,
Goutan E, Blanco R, Tolosa E and Martí E: BDNF and full-length and
truncated TrkB expression in Alzheimer disease. Implications in
therapeutic strategies. J Neuropathol Exp Neurol. 58:729–739. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Aicardi G, Argilli E, Cappello S, Santi S,
Riccio M, Thoenen H and Canossa M: Induction of long-term
potentiation and depression is reflected by corresponding changes
in secretion of endogenous brain-derived neurotrophic factor. Proc
Natl Acad Sci USA. 101:15788–15792. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Poo MM: Neurotrophins as synaptic
modulators. Nat Rev Neurosci. 2:24–32. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ventriglia M, Bocchio Chiavetto L, Benussi
L, Binetti G, Zanetti O, Riva MA and Gennarelli M: Association
between the BDNF 196 A/G polymorphism and sporadic Alzheimer's
disease. Mol Psychiatry. 7:136–137. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Saarela MS, Lehtimaki T, Rinne JO, Huhtala
H, Rontu R, Hervonen A, Roytta M, Ahonen JP and Mattila KM: No
association between the brain-derived neurotrophic factor 196
G>;A or 270 C>T polymorphisms and Alzheimer's or Parkinson's
disease. Folia Neuropathol. 44:12–16. 2006.PubMed/NCBI
|
|
14
|
Fehér A, Juhász A, Rimanóczy A, Kálmán J
and Janka Z: Association between BDNF Val66Met polymorphism and
Alzheimer disease, dementia with Lewy bodies, and Pick disease.
Alzheimer Dis Assoc Disord. 23:224–228. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pivac N, Nikolac M, Nedic G, et al: Brain
derived neurotrophic factor Val66Met polymorphism and psychotic
symptoms in Alzheimer's disease. Prog Neuropsychopharmacol Biol
Psychiatry. 35:356–362. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Matsushita S, Arai H, Matsui T, Yuzuriha
T, Urakami K, Masaki T and Higuchi S: Brain-derived neurotrophic
factor gene polymorphisms and Alzheimer's disease. J Neural Transm.
112:703–711. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Olin D, MacMurray J and Comings DE: Risk
of late-onset Alzheimer's disease associated with BDNF C270T
polymorphism. Neurosci Lett. 381:275–278. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kunugi H, Ueki A, Otsuka M, Isse K,
Hirasawa H, Kato N, Nabika T, Kobayashi S and Nanko S: A novel
polymorphism of the brain-derived neurotrophic factor (BDNF) gene
associated with late-onset Alzheimer's disease. Mol Psychiatry.
6:83–86. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nishimura M, Kuno S, Kaji R and Kawakami
H: Brain-derived neurotrophic factor gene polymorphisms in Japanese
patients with sporadic Alzheimer's disease, Parkinson's disease,
and multiple system atrophy. Mov Disord. 20:1031–1033. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Allderdice PW, Gardner HA, Galutira D,
Lockridge O, LaDu BN and McAlpine PJ: The cloned
butyrylcholinesterase (BCHE) gene maps to a single chromosome site,
3q26. Genomics. 11:452–454. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Arpagaus M, Kott M, Vatsis KP, Bartels CF,
La Du BN and Lockridge O: Structure of the gene for human
butyrylcholinesterase. Evidence for a single copy. Biochemistry.
29:124–131. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Perry E, McKeith I and Ballard C:
Butyrylcholinesterase and progression of cognitive deficits in
dementia with Lewy bodies. Neurology. 60:1852–1853. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Arendt T, Brückner MK, Lange M and Bigl V:
Changes in acetylcholinesterase and butyrylcholinesterase in
Alzheimer's disease resemble embryonic development - a study of
molecular forms. Neurochem Int. 21:381–396. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Carson KA, Geula C and Mesulam MM:
Electron microscopic localization of cholinesterase activity in
Alzheimer brain tissue. Brain Res. 540:204–208. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Darvesh S, Cash MK, Reid GA, Martin E,
Mitnitski A and Geula C: Butyrylcholinesterase is associated with
β-amyloid plaques in the transgenic APPSWE/PSEN1dE9 mouse model of
Alzheimer disease. J Neuropathol Exp Neurol. 71:2–14. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nacmias B, Piccini C, Bagnoli S, Tedde A,
Cellini E, Bracco L and Sorbi S: Brain-derived neurotrophic factor,
apolipoprotein E genetic variants and cognitive performance in
Alzheimer's disease. Neurosci Lett. 367:379–383. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Combarros O, Infante J, Llorca J and
Berciano J: Polymorphism at codon 66 of the brain-derived
neurotrophic factor gene is not associated with sporadic
Alzheimer's disease. Dement Geriatr Cogn Disord. 18:55–58. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lee J, Fukumoto H, Orne J, Klucken J, Raju
S, Vanderburg CR, Irizarry MC, Hyman BT and Ingelsson M: Decreased
levels of BDNF protein in Alzheimer temporal cortex are independent
of BDNF polymorphisms. Exp Neurol. 194:91–96. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Desai P, Nebes R, DeKosky ST and Kamboh
MI: Investigation of the effect of brain-derived neurotrophic
factor (BDNF) polymorphisms on the risk of late-onset Alzheimer's
disease (AD) and quantitative measures of AD progression. Neurosci
Lett. 379:229–234. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Vepsӓlӓinen S, Castren E, Helisalmi S,
Iivonen S, Mannermaa A, Lehtovirta M, Hӓnninen T, Soininen H and
Hiltunen M: Genetic analysis of BDNF and TrkB gene polymorphisms in
Alzheimer's disease. J Neurol. 252:423–428. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bodner SM, Berrettini W, van Deerlin V,
Bennett DA, Wilson RS, Trojanowski JQ and Arnold SE: Genetic
variation in the brain derived neurotrophic factor gene in
Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet.
134B:1–5. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li Y, Rowland C, Tacey K, et al: The BDNF
Val66Met polymorphism is not associated with late onset Alzheimer's
disease in three case-control samples. Mol Psychiatry. 10:809–810.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Forero DA, Benítez B, Arboleda G, Yunis
JJ, Pardo R and Arboleda H: Analysis of functional polymorphisms in
three synaptic plasticity-related genes (BDNF, COMT AND UCHL1) in
Alzheimer's disease in Colombia. Neurosci Res. 55:334–341. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang H, Ozbay F, Lappalainen J, et al:
Brain derived neurotrophic factor (BDNF) gene variants and
Alzheimer's disease, affective disorders, posttraumatic stress
disorder, schizophrenia, and substance dependence. Am J Med Genet B
Neuropsychiatr Genet. 141B:387–393. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Huang R, Huang J, Cathcart H, Smith S and
Poduslo SE: Genetic variants in brain-derived neurotrophic factor
associated with Alzheimer's disease. J Med Genet. 44:e662007.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Boiocchi C, Maggioli E, Zorzetto M,
Sinforiani E, Cereda C, Ricevuti G and Cuccia M: Brain-derived
neurotrophic factor gene variants and Alzheimer disease: An
association study in an Alzheimer disease Italian population.
Rejuvenation Res. 16:57–66. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Cozza A, Melissari E, Iacopetti P,
Mariotti V, Tedde A, Nacmias B, Conte A, Sorbi S and Pellegrini S:
SNPs in neurotrophin system genes and Alzheimer's disease in an
Italian population. J Alzheimers Dis. 15:61–70. 2008.PubMed/NCBI
|
|
38
|
Tsai SJ, Hong CJ, Liu HC, Liu TY, Hsu LE
and Lin CH: Association analysis of brain-derived neurotrophic
factor Val66Met polymorphisms with Alzheimer's disease and age of
onset. Neuropsychobiology. 49:10–12. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bian JT, Zhang JW, Zhang ZX and Zhao HL:
Association analysis of brain-derived neurotrophic factor (BDNF)
gene 196 A/G polymorphism with Alzheimer's disease (AD) in mainland
China. Neurosci Lett. 387:11–16. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Akatsu H, Yamagata HD, Kawamata J, Kamino
K, Takeda M, Yamamoto T, Miki T, Tooyama I, Shimohama S and Kosaka
K: Variations in the BDNF gene in autopsy-confirmed Alzheimer's
disease and dementia with Lewy bodies in Japan. Dement Geriatr Cogn
Disord. 22:216–222. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Tsai SJ, Hong CJ, Liu HC, Liu TY and Liou
YJ: The brain-derived neurotrophic factor gene as a possible
susceptibility candidate for Alzheimer's disease in a Chinese
population. Dement Geriatr Cogn Disord. 21:139–143. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
He XM, Zhang ZX, Zhang JW, Zhou YT, Tang
MN, Wu CB and Hong Z: Lack of association between the BDNF gene
Val66Met polymorphism and Alzheimer disease in a Chinese Han
population. Neuropsychobiology. 55:151–155. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Riemenschneider M, Schwarz S, Wagenpfeil
S, Diehl J, Müller U, Förstl H and Kurz A: A polymorphism of the
brain-derived neurotrophic factor (BDNF) is associated with
Alzheimer's disease in patients lacking the Apolipoprotein E
epsilon4 allele. Mol Psychiatry. 7:782–785. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Nishimura AL, Oliveira JR, Mitne-Neto M,
Guindalini C, Nitrini R, Bahia VS, de Brito-Marques PR, Otto PA and
Zatz M: Lack of association between the brain-derived neurotrophin
factor (C-270T) polymorphism and late-onset Alzheimer's disease
(LOAD) in Brazilian patients. J Mol Neurosci. 22:257–260. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Cousin E, Macé S, Rocher C, et al: No
replication of genetic association between candidate polymorphisms
and Alzheimer's disease. Neurobiol Aging. 32:1443–1451. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Combarros O, Riancho JA, Infante J, Sañudo
C, Llorca J, Zarrabeitia MT and Berciano J: Interaction between
CYP19 aromatase and butyrylcholinesterase genes increases
Alzheimer's disease risk. Dement Geriatr Cogn Disord. 20:153–157.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Raygani AV, Zahrai M, Soltanzadeh A,
Doosti M, Javadi E and Pourmotabbed T: Analysis of association
between butyrylcholinesterase K variant and apolipoprotein E
genotypes in Alzheimer's disease. Neurosci Lett. 371:142–146. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Alvarez-Arcaya A, Combarros O, Llorca J,
Sánchez-Guerra M, Berciano J, Fernández-Viadero C and Peña N: The
butyrylcholinesterase K variant is a protective factor for sporadic
Alzheimer's disease in women. Acta Neurol Scand. 102:350–353. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
McIlroy SP, Crawford VL, Dynan KB,
McGleenon BM, Vahidassr MD, Lawson JT and Passmore AP:
Butyrylcholinesterase K variant is genetically associated with late
onset Alzheimer's disease in Northern Ireland. J Med Genet.
37:182–185. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Wiebusch H, Poirier J, Sévigny P and
Schappert K: Further evidence for a synergistic association between
APOE epsilon4 and BCHE-K in confirmed Alzheimer's disease. Hum
Genet. 104:158–163. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Lehmann DJ, Johnston C and Smith AD:
Synergy between the genes for butyrylcholinesterase K variant and
apolipoprotein E4 in late-onset confirmed Alzheimer's disease. Hum
Mol Genet. 6:1933–1936. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Simão-Silva DP, Bertolucci PH, de Labio
RW, Payão SL, Furtado-Alle L and Souza RL: Association analysis
between K and −116A variants of butyrylcholinesterase and
Alzheimer's disease in a Brazilian population. Chem Biol Interact.
203:358–360. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Mateo I, Llorca J, Infante J,
Rodríguez-Rodríguez E, Berciano J and Combarros O: Gene-gene
interaction between 14-3-3 zeta and butyrylcholinesterase modulates
Alzheimer's disease risk. Eur J Neurol. 15:219–222. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Déniz-Naranjo MC, Muñoz-Fernández C,
Alemany-Rodríguez MJ, del Carmen Pérez-Vieitez M, Aladro-Benito Y,
Irurita-Latasa J and Sánchez-García F: Butyrylcholinesterase, ApoE
and Alzheimer's disease in a population from the Canary Islands
(Spain). Neurosci Lett. 427:34–38. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Piccardi M, Congiu D, Squassina A, Manconi
F, Putzu PF, Mereu RM, Chillotti C and Del Zompo M: Alzheimer's
disease: Case-control association study of polymorphisms in ACHE,
CHAT, and BCHE genes in a Sardinian sample. Am J Med Genet B
Neuropsychiatr Genet. 144B:895–899. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Prince JA, Feuk L, Sawyer SL, Gottfries J,
Ricksten A, Nӓgga K, Bogdanovic N, Blennow K and Brookes AJ: Lack
of replication of association findings in complex disease: An
analysis of 15 polymorphisms in prior candidate genes for sporadic
Alzheimer's disease. Eur J Hum Genet. 9:437–444. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Mattila KM, Rinne JO, Röyttӓ M, Laippala
P, Pietilӓ T, Kalimo H, Koivula T, Frey H and Lehtimӓki T:
Dipeptidyl carboxypeptidase 1 (DCP1) and butyrylcholinesterase
(BCHE) gene interactions with the apolipoprotein E epsilon4 allele
as risk factors in Alzheimer's disease and in Parkinson's disease
with coexisting Alzheimer pathology. J Med Genet. 37:766–770. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Tilley L, Morgan K, Grainger J, Marsters
P, Morgan L, Lowe J, Xuereb J, Wischik C, Harrington C and
Kalsheker N: Evaluation of polymorphisms in the presenilin-1 gene
and the butyrylcholinesterase gene as risk factors in sporadic
Alzheimer's disease. Eur J Hum Genet. 7:659–663. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Grubber JM, Saunders AM, Crane-Gatherum
AR, et al: Analysis of association between Alzheimer disease and
the K variant of butyrylcholinesterase (BCHE-K). Neurosci Lett.
269:115–119. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Kehoe PG, Williams H, Holmans P, Wilcock
G, Cairns NJ, Neal J and Owen MJ: The butyrylcholinesterase K
variant and susceptibility to Alzheimer's disease. J Med Genet.
35:1034–1035. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Hiltunen M, Mannermaa A, Helisalmi S,
Koivisto A, Lehtovirta M, Ryynӓnen M, Riekkinen P and Soininen H:
Butyrylcholinesterase K variant and apolipoprotein E4 genes do not
act in synergy in Finnish late-onset Alzheimer's disease patients.
Neurosci Lett. 250:69–71. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Crawford F, Fallin D, Suo Z, Abdullah L,
Gold M, Gauntlett A, Duara R and Mullan M: The
butyrylcholinesterase gene is neither independently nor
synergistically associated with late-onset AD in clinic- and
community-based populations. Neurosci Lett. 249:115–118. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Singleton AB, Smith G, Gibson AM, Woodward
R, Perry RH, Ince PG, Edwardson JA and Morris CM: No association
between the K variant of the butyrylcholinesterase gene and
pathologically confirmed Alzheimer's disease. Hum Mol Genet.
7:937–939. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Brindle N, Song Y, Rogaeva E, et al:
Analysis of the butyrylcholinesterase gene and nearby chromosome 3
markers in Alzheimer disease. Hum Mol Genet. 7:933–935. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Russ C, Powell J, Lovestone S and Holmes
C: K variant of butyrycholinesterase and late-onset Alzheimer's
disease. Lancet. 351:8811998. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Helbecque N: The butyrylcholinesterase K
variant is not associated with Alzheimer's. Alzheimers Rep.
1:309–313. 1998.
|
|
67
|
Laws SM: Evidence that the
butyrylcholinesterase K variant can protect against late-onset
Alzheimer's disease. Alzheimers Rep. 2:219–223. 1999.
|
|
68
|
Bi S, Zhang Y, Wu J, Wang D and Zhao Q:
Association between low-density lipoprotein receptor-related
protein gene, butyrylcholinesterase gene and Alzheimer's disease in
Chinese. Chin Med Sci J. 16:71–75. 2001.PubMed/NCBI
|
|
69
|
Lee DW, Liu HC, Liu TY, Chi CW and Hong
CJ: No association between butyrylcholinesterase K-variant and
Alzheimer disease in Chinese. Am J Med Genet. 96:167–169. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Yamamoto Y, Yasuda M, Mori E and Maeda K:
Failure to confirm a synergistic effect between the K-variant of
the butyrylcholinesterase gene and the epsilon4 allele of the
apolipoprotein gene in Japanese patients with Alzheimer's disease.
J Neurol Neurosurg Psychiatry. 67:94–96. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Ki CS, Na DL, Kim JW, Kim HJ, Kim DK and
Yoon BK: No association between the genes for butyrylcholinesterase
K variant and apolipoprotein E4 in late-onset Alzheimer's disease.
Am J Med Genet. 88:113–115. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Yamada M, Sodeyama N, Itoh Y, Suematsu N,
Otomo E, Matsushita M and Mizusawa H: Butyrylcholinesterase K
variant and cerebral amyloid angiopathy. Stroke. 29:2488–2490.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Xu X, Wang Y, Wang L, et al: Meta-analyses
of 8 polymorphisms associated with the risk of the Alzheimer's
disease. PLoS One. 8:e731292013. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Dai D, Wang Y, Wang L, et al:
Polymorphisms of DRD2 and DRD3 genes and Parkinson's disease: A
meta-analysis. Biomed Rep. 2:275–281. 2014.PubMed/NCBI
|
|
75
|
Zhou J, Huang Y, Huang RS, et al: A
case-control study provides evidence of association for a common
SNP rs974819 in PDGFD to coronary heart disease and suggests a
sex-dependent effect. Thromb Res. 130:602–606. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Excoffier L, Laval G and Schneider S:
Arlequin (version 3.0): An integrated software package for
population genetics data analysis. Evol Bioinform Online. 1:47–50.
2005.
|
|
77
|
Gibson E, Fenster A and Ward AD: The
impact of registration accuracy on imaging validation study design:
A novel statistical power calculation. Med Image Anal. 17:805–815.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Coory MD: Comment on: Heterogeneity in
meta-analysis should be expected and appropriately quantified. Int
J Epidemiol. 39:932–933. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Kawalec P, Mikrut A, Wiśniewska N and Pilc
A: The effectiveness of tofacitinib, a novel Janus kinase
inhibitor, in the treatment of rheumatoid arthritis: a systematic
review and meta-analysis. Clin Rheumatol. 32:1415–1424. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
80
|
McHughen SA, Rodriguez PF, Kleim JA, Kleim
ED, Marchal Crespo L, Procaccio V and Cramer SC: BDNF val66met
polymorphism influences motor system function in the human brain.
Cereb Cortex. 20:1254–1262. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Pezawas L, Verchinski BA, Mattay VS,
Callicott JH, Kolachana BS, Straub RE, Egan MF, Meyer-Lindenberg A
and Weinberger DR: The brain-derived neurotrophic factor val66met
polymorphism and variation in human cortical morphology. J
Neurosci. 24:10099–10102. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Fukumoto N, Fujii T, Combarros O, et al:
Sexually dimorphic effect of the Val66Met polymorphism of BDNF on
susceptibility to Alzheimer's disease: New data and meta-analysis.
Am J Med Genet B Neuropsychiatr Genet. 153B:235–242.
2010.PubMed/NCBI
|
|
83
|
Nagata T, Shinagawa S, Nukariya K, Ochiai
Y, Kawamura S, Agawa-Ohta M, Kasahara H, Nakayama K and Yamada H:
Association between brain-derived neurotrophic factor (BDNF) gene
polymorphisms and executive function in Japanese patients with
Alzheimer's disease. Psychogeriatrics. 11:141–149. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Guillozet AL, Smiley JF, Mash DC and
Mesulam MM: Butyrylcholinesterase in the life cycle of amyloid
plaques. Ann Neurol. 42:909–918. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Lehmann DJ, Nagy Z, Litchfield S, Borja MC
and Smith AD: Association of butyrylcholinesterase K variant with
cholinesterase-positive neuritic plaques in the temporal cortex in
late-onset Alzheimer's disease. Hum Genet. 106:447–452. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Lehmann DJ, Williams J, McBroom J and
Smith AD: Using meta-analysis to explain the diversity of results
in genetic studies of late-onset Alzheimer's disease and to
identify high-risk subgroups. Neuroscience. 108:541–554. 2001.
View Article : Google Scholar : PubMed/NCBI
|
